Xi Ren
Assistant Professor, Biomedical Engineering
Courtesy Appointment, Mechanical Engineering
Xi (Charlie) Ren was trained as a developmental biologist during his graduate study focusing on the vascular and hematopoietic systems. Moving from vascular development to vascular engineering, he joined the Laboratory for Organ Engineering and Regeneration at Massachusetts General Hospital and Harvard Medical School as a Postdoctoral Research Fellow in 2012. He became Instructor in Surgery at Harvard Medical School in 2016. During this time, he developed systematic strategies for engineering functional vasculature based on decellularized organ scaffolds. He joined the faculty of the Department of Biomedical Engineering at Carnegie Mellon University in 2017.
Demonstration: Decellularizing a Lung Using Detergent Perfusion
Engineering Organ-Specific Vasculature
Education
2011 Ph.D., Cell Biology, Peking University
2005 BS, Biological Science, Peking University
Affiliations
Research Interests
Media mentions
Ren and Yerneni honored with BMES-CMBE Awards
The Biomedical Engineering Society (BMES) recently announced its 2023 Cellular and Molecular Bioengineering (CMBE) award winners, and two Carnegie Mellon engineers were named recipients. BME’s Charlie Ren, was selected for the CMBE Rising Star Award. Sai Yerneni, a former biomedical engineering Ph.D. student who is continuing his research as a chemical engineering postdoc, received the CMBE Graduate Student Travel Award.
CMU Engineering
Halilaj and Ren receive NSF Career Awards
College of Engineering’s Eni Halilaj and Charlie Ren have received National Science Foundation CAREER Awards for their research.
Northeast Bioengineering Conference
Ren accepts New Innovator Award at Northeast Bioengineering Conference
BME’s Charlie Ren was awarded the New Innovator Award for Junior Faculty at the 48th annual Northeast Bioengineering Conference hosted at Columbia University. Ren’s lab works at the interface of biomaterial and stem cell engineering, with the goal of providing regenerative therapeutic solutions to repair or replace damaged tissues and organs.
CMU Engineering
It takes a heart to make a better lung
A team of collaborators from CMU and Boston University present a human model of heart and lung co-development during embryogenesis using lab-grown human induced pluripotent stem cells.
CMU Engineering
Collaboration shapes extracellular vesicle retention strategy
Phil Campbell and Charlie Ren present a strategy to spatially control extracellular vesicles and keep them resolute under controlled conditions.
CMU Engineering
CMU and Mayo Clinic to collaborate on transplant innovation
Mayo Clinic and Carnegie Mellon University announced today a research agreement to transform organ transplantation. The institutions will bioengineer innovative approaches to address current barriers in organ transplantation.
National Academy of Medicine
Ren receives Healthy Longevity Catalyst Award
BME’s Charlie Ren was named an awardee of the National Academy of Medicine’s 2021 Healthy Longevity Catalyst Awards.
the Bioengineered Organs Initiative
Scott and Ng win cardiovascular award
BME Ph.D. students Jacqueline Scott and Wai Hoe Ng won awards for presenting research at AHA’s 28th Annual Fellows Research Day.
Ph.D. students win cardiovascular award
BME Ph.D. students Jacqueline Scott and Wai Hoe Ng won awards for presenting research at AHA’s 28th Annual Fellows Research Day on January 17. Scott won first in clinical, and Ng won second in basic.
CMU Engineering
Creating lungs “from scratch”
There are many ways to make a lung. With so many possible approaches, where do you even start? CMU Ph.D. student Erica Comber has the answer.
Science News
Ren comments on potential organ bioengineering breakthrough
BME’s Charlie Ren spoke with Science News on the significance of a recent breakthrough in bioengineered organs by a group of researchers published in Science Translational Magazine.
CMU Engineering
Laying the foundation: Organ bioengineering
Charlie Ren’s work on bioengineering lungs could one day help thousands of patients with end-stage lung diseases breathe easier.